New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:51 EDTAPRIApricus Biosciences upgraded to Buy from Hold at Cantor
Cantor Fitzgerald upgraded Apricus Biosciences to Buy citing potential upcoming pipeline catalysts. The firm raised its price target for shares to $3 from $2.50.
News For APRI From The Last 14 Days
Check below for free stories on APRI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for APRI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use